Literature DB >> 6357308

Antigenic heterogeneity of human mononuclear phagocytes: immunohistologic analysis using monoclonal antibodies.

W W Hancock, H Zola, R C Atkins.   

Abstract

Eight monoclonal antibodies to cell surface antigens of human monocytes were evaluated as immunologic markers for recognition of macrophages in sections of normal and diseased tissues, using immunoperoxidase and enzyme histochemical techniques. Monoclonal antibodies assessed were PHM2, PHM3, FMC17, FMC32, FMC33, FMC34, OKM1, and 63D3. Sites studied were human bone marrow, blood, lymph node, spleen, thymus, liver, kidney, lung, and peritoneal lavages, rejecting renal allografts containing inflammatory macrophages, and granulomata showing epithelioid and multinucleate giant cell formation. All antibodies bound to at least some tissue macrophages and, except for FMC32 and FMC33 antibodies, which were identically distributed, each antibody had a distinctive tissue distribution. Some antigens were shared by other bone-marrow-derived cells (megakaryocytes and cortical thymocytes), endothelium, epithelium, and dendritic cells. Antigenic differences were also detected between mononuclear phagocytes present at different sites, different stages of differentiation, and likely different states of activation. These studies provide evidence of major antigenic differences between various populations of human mononuclear phagocytes. They therefore indicate the need for careful evaluation of experiments involving the recognition of macrophages in tissue sections and smears based solely on the use of antimonocyte monoclonal antibodies.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6357308

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  28 in total

1.  A monocyte/macrophage antigen recognized by the four antibodies GHI/61, Ber-MAC3, Ki-M8 and SM4.

Authors:  K Pulford; K Micklem; S McCarthy; J Cordell; M Jones; D Y Mason
Journal:  Immunology       Date:  1992-04       Impact factor: 7.397

2.  Nodular alteration of the paracortical area. An in situ immunohistochemical analysis of primary, secondary, and tertiary T-nodules.

Authors:  J J van den Oord; C De Wolf-Peeters; V J Desmet; K Takahashi; Y Ohtsuki; T Akagi
Journal:  Am J Pathol       Date:  1985-07       Impact factor: 4.307

3.  Transmembrane 4 superfamily protein CD151 (PETA-3) associates with beta 1 and alpha IIb beta 3 integrins in haemopoietic cell lines and modulates cell-cell adhesion.

Authors:  S Fitter; P M Sincock; C N Jolliffe; L K Ashman
Journal:  Biochem J       Date:  1999-02-15       Impact factor: 3.857

4.  Granulocyte and monocyte surface membrane markers in the myelodysplastic syndromes.

Authors:  R E Clark; T G Hoy; A Jacobs
Journal:  J Clin Pathol       Date:  1985-03       Impact factor: 3.411

5.  Mac 387 antibody and detection of formalin resistant myelomonocytic L1 antigen.

Authors:  P Brandtzaeg; D B Jones; D J Flavell; M K Fagerhol
Journal:  J Clin Pathol       Date:  1988-09       Impact factor: 3.411

6.  The phenotype of human placental macrophages and its variation with gestational age.

Authors:  J Goldstein; M Braverman; C Salafia; P Buckley
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

7.  Immunohistochemical study of mononuclear phagocyte antigens in giant cell tumor of bone.

Authors:  M E Brecher; W A Franklin; M A Simon
Journal:  Am J Pathol       Date:  1986-11       Impact factor: 4.307

8.  Immunocytochemical characterisation of cutaneous lymphomas other than mycosis fungoides.

Authors:  E Ralfkiaer; T A Saati; J Bosq; G Delsol; K C Gatter; D Y Mason
Journal:  J Clin Pathol       Date:  1986-05       Impact factor: 3.411

9.  Phenotypic transformation of macrophages to Langerhans cells in the skin.

Authors:  G F Murphy; D Messadi; E Fonferko; W W Hancock
Journal:  Am J Pathol       Date:  1986-06       Impact factor: 4.307

10.  Four monoclonal antibodies, AMH-1, -2, -3, and -4, give varied reactivities with monocytes, alveolar macrophages, and epithelioid-cell granulomas.

Authors:  J Akiyama; K Chida; A Sato; A Yamashita
Journal:  J Clin Immunol       Date:  1988-09       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.